MODULATE trial results, page-23

you've got a real vendetta against this stock.. you've sold out.. why not move on and leave the rest of us to make our own decisions.

My decision is to stay and expect all these troughs along the way.. Peter Thiel and Merck research partner is a good basis.
Just re read the Director's last report a couple of months ago and it's all good. Nothing unexpected with this type of stock.
Looking at the LT chart can see this has hit even lower before zooming up a number of times..

You are hanging around like a bad smell hoping to extract revenge for your losses. Move on!